Patient Data. Exhibits Mark whether the assessment finding represents a therapeutic result of the drug administered, a nontherapeutic side effect, or an unrelated finding. Each row must have one option selected.

Rationale: Cold, swollen hand: This is related to infiltration of the IV site rather than the pharmacologic effects of albuterol. Tissue swelling and coldness reflect fluid extravasation and poor perfusion at the old IV site. Heart rate 110 beats/minute: Albuterol stimulates beta-2 adrenergic receptors in the airways but can also stimulate beta-1 receptors in the heart at higher systemic concentrations. This produces reflex tachycardia, seen here as a heart rate of 110 bpm, which is a nontherapeutic adverse effect requiring monitoring. Temperature 101.5° F (38.6° C): Fever is most consistent with the underlying respiratory infection, likely pneumonia or bronchitis, rather than albuterol use. The rise in temperature indicates disease progression rather than a medication effect. Tremble: Tremors occur because of beta-2 stimulation in skeletal muscles, leading to increased excitability at neuromuscular junctions. This is one of the most common side effects of short-acting beta-agonists like albuterol, reflecting systemic drug activity. Oxygen saturation 99%: Improved SpO₂ after albuterol nebulization indicates reversal of bronchospasm and enhanced alveolar ventilation. Oxygen delivery and gas exchange are optimized, reflecting the desired therapeutic effect of treatment. Sore nose: Nasal irritation is linked to prolonged use of oxygen via nasal cannula, which can dry out nasal mucosa. It is not a side effect of albuterol and should be managed with humidification or skin care, not by altering the bronchodilator. Clear breath sounds: The disappearance of wheezes and coarse crackles after albuterol therapy demonstrates effective bronchodilation and improved airflow through previously obstructed lower airways, confirming the drug’s clinical benefit.